Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19

67Citations
Citations of this article
194Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific treatment against SARS-CoV-2, effective vaccines and antiviral agents are urgently needed to properly restrain the COVID-19 pandemic. Repositioned drugs such as remdesivir have revealed a promising clinical efficacy against COVID-19. Interestingly, nanomedicine as a promising therapeutic approach could effectively help win the battle between coronaviruses (CoVs) and host cells. This review discusses the potential therapeutic approaches, in addition to the contribution of nanomedicine against CoVs in the fields of vaccination, diagnosis and therapy.

Cite

CITATION STYLE

APA

Abd Ellah, N. H., Gad, S. F., Muhammad, K., E Batiha, G., & Hetta, H. F. (2020, September 1). Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine. Future Medicine Ltd. https://doi.org/10.2217/nnm-2020-0247

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free